Search
You're invited to try out the new version of Value Research Online. Click here to begin: https://beta.valueresearchonline.com

Parabolic Drugs

Sector: Healthcare | Industry: Drugs & Pharma
R 1.05 0.05  | 5.00% -61.82% - 6.31
NSE Price: Oct 23, 15:31 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Oct 23, 15:31 1.05 0.05 5.00% 0.95 1.00 7,755 0.95 - 1.05
BSE Oct 23, 2019 1.02 0.00 0.00% 1.02 1.02 32,500 1.02 - 1.02
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
GET STOCK UPDATES FROM VALUE RESEARCH IN YOUR INBOX
6M Average Volume: 15,837 P/B: -0.01 NSE Code: PARABDRUGS
52-Week Range: R 0.45 - 3.15 Dividend Yield: 0.00% BSE Code: 533211
TTM EPS: R -5.78 Book Value: R -148.77 Face Value: R 10
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 38
Price Graph
  • Eris Lifesciences (NSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Are you missing an opportunity to invest in great stocks at low valuations?
There are thousands of listed companies in India and yet only a handful that are worth investing at a particular time and at a particular price.

Our equity team has sifted through hundreds of companies and selected stocks that you should invest in. This list now has 38 stocks on it, and new ones are being added every month. Thousands of our members are using stagnant equity markets to buy great stocks at low prices. Membership of Value Research Stock Advisor is available at a 40% to 60% discount. Learn more and become a member
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Parabolic Drugs -61.54 5.26 53.85 -63.64 -51.00 -40.95 -
S&P BSE Small Cap -10.09 -2.52 0.13 -3.04 -0.52 4.40 5.59
S&P BSE Healthcare -7.63 -0.83 0.63 -9.28 -7.66 -1.57 11.31
Company's return has been calculated on basis of NSE's price.
As on Oct 23, 2019
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue -2.33 -31.95 -37.49
Net Profit 46.76 22.73 9.88
EPS 46.76 22.73 9.87
Book Value -5.32 -190.75 -254.04
Average
Operating Margin -34.04 -195.79 -133.90
Net Margin -74.43 -279.06 -205.97
Return on Networth 0.00 0.00 -46.76
Return on Investment -31.96 -54.11 -39.50
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue - -100.00 -100.00
Operating Profit 1.02 58.90 37.82
Net Profit 13.91 28.80 47.51
EPS -9.82 28.80 47.51
TTM
Revenue -71.07 -92.47 -92.80
Operating Profit 19.94 28.96 6.61
Net Profit 7.45 30.95 33.50
EPS 7.81 34.40 36.83
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Parabolic Drugs 6.31 5.23 -37.63 -603.89 0.00 -0.01 -
Astrazeneca Pharma India 6,332.38 771.42 69.56 8.84 20.03 19.78 91.03
Eris Lifesciences 5,764.14 1,005.70 303.64 29.29 28.96 4.67 18.99
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Jan 06, 2016 BTS India Pvt Equity Fund Ltd  Sell Market 687,081 10.20 70.08
Dec 28, 2015 BTS India Pvt Equity Fund Ltd  Sell Market 1,391,000 9.50 132.15
Jul 03, 2014 Parabolic Infrastructure Pvt. Ltd.  Buy Market 26,424 8.95 2.36
Jun 25, 2014 Parabolic Infrastructure Pvt. Ltd.  Buy Market 44,653 7.50 3.35
Jun 25, 2014 Parabolic Infrastructure Pvt. Ltd.  Sell Market 7,740 7.50 0.58
Fund Houses invested in the stock
Fund Mar-13 Dec-12 Sep-12 Jun-12 Mar-12
UTI Mutual Fund 0.481 0.899 1.900 2.457 2.301
Figures given above are % of equity capital
News & Announcements
Contact Information

Company: Parabolic Drugs Ltd.

Address: S.c.o. 186-187, 2nd Floor, Sector 8c, Chandigarh, Punjab - 160017 | Phone: +91-172-3914646/3914647/38 | Fax: +91-172-3914645

Website: www.parabolicdrugs.com

Registrar & Transfer Agent: Link Intime India Pvt Ltd.

Address: Narang Tower 44, Community Centre,Naraina Industrial Area Phase - 1,New Delhi - 110 028, Narang Tower 44, Community Centre, Naraina Industrial Area, Phase - 1

Email: [email protected]

Essential checks
Altman Z-Score
-4.42
Piotroski F-Score
6
Modified C-Score
1
3-Years Price to Earnings
Not applicable
3-Years Price to Book
-0.01
Earnings Yield
EBIT / Enterprise value
-3.31%
PEG
Price / Earnings to growth ratio
Not available
Related Stocks
  Current Price   Chng %
Astrazeneca Pharma India R2,531.95 +4.97%
Caplin Point Laboratories R382.95 -1.24%
Eris Lifesciences R421.25 -0.98%
FDC R159.30 -1.03%
JB Chemicals & Pharma R355.00 -1.33%
Laurus Labs R348.00 +1.84%
Strides Pharma Science R343.50 -2.07%
Sun Pharma Adv. Research R129.30 -2.49%
Suven Life Sciences R288.40 +0.61%
Wockhardt R269.80 -1.96%
As on Oct 23, 15:59